Healthcare

ResApp Health

ResApp Health Limited Encounters Steep Sell-Off, Nosedived More Than 50% Today

As market commenced trading today, ResApp stock price rushed to hit the gravity lifting the suspension that was in place since last 10 days....
Medlab Clinical

Stage 1 Trial Of NANABIS Is A Success. DSMB Showed A Green Flag To...

Trial Background Information: The RNS trial was performed under 2 distinct stages. In stage 1 of the trial which is the safety and tolerable phase...

Capio Shareholders Have Given A Green Card To $1.3 Billion Acquisition Bid From Ramsay

Despite struggling through the weaker financial performance Ramsay Health Care Limited  (ASX: RHC) got a heads up to the acquisition of Sweden based healthcare...
pharmaust

PharmAust To Increase Production of Monepantel: What You Should Know

PharmAust Limited (ASX: PAA) is all set to increase the development of the drug candidate named “Monepantel” which is applicable to the pets and...
bwx limited

Q2FY2019 Will Not Suffer The Hindrances Of Q1FY2019- Says Myles Anceschi

Before the commencement of the AGM on Wednesday 31 October 2018, BWX Limited (ASX: BWX) made an announcement that for the 2019 financial year...

Opthea’s Phase 1 Clinical Trial Of OPT-302 Is A Success

Opthea Limited (ASX:OPT) has come into limelight with an encouraging data released from its Phase 1b dose escalation study of a key drug against...
CMP

Compumedics China JV Update

Compumedics Limited (ASX: CMP) shares an update regarding the contract negotiations with the Somfit technology which is China’s leading health-check organization, Meinian Onehealth Healthcare...
RMD

ResMed Flags 13% Revenue Growth For September 2018 Quarter

California-based health company ResMed Inc (ASX: RMD) has released its quarterly results for the period ended 30 September 2018. ResMed has started Fiscal 2019 with...
1st group

1st Group Made Continuous Growth In Annualized Contract Value (ACV) Followed By Positive Q2...

1st Group Limited (ASX: 1ST) made an announcement of its quarterly update for the quarter ended 30 September 2018. The revenue presented remains unaudited....
BIT

Biotron’s Bosses Exercised Options To Sell Down Their Million-Dollar Stakes

Biotron Limited (ASX: BIT) crashed 17.5% after its bosses in-cashed their underlying options when stock was trading at its highest peak. On 25 October 2018,...

Recent News